美股市場個股詳情
AUTL Autolus Therapeutics
- 2.840
- +0.040+1.43%
收盤價 11/21 16:00 (美東)
- 2.860
- +0.020+0.70%
盤後 16:24 (美東)
7.56億總市值-2327市盈率TTM
2.895最高價2.690最低價380.96萬股成交量2.830今開2.800昨收1064.99萬成交額2.84%換手率虧損市盈率(靜)2.66億總股本7.45052周最高1.58市淨率3.82億流通值2.69052周最低--股息TTM1.34億流通股53.240歷史最高--股息率TTM7.32%振幅1.600歷史最低2.795平均價1股每手
關於Autolus Therapeutics公司
Autolus Therapeutics PLC 是一家生物製藥公司，致力於開發用於治療癌症的下一代程序化 T 細胞療法。 公司臨牀階段管線包括Obe-cel（obecabtagene autoleucel）、AUTO1/22、AUTO3、AUTO5、AUTO6、AUTO7和AUTO8。
公司介紹
公司代碼AUTL
公司名稱Autolus Therapeutics
上市日期2018/06/22
發行價格17.00
成立日期2018
CEODr. Christian Itin, PhD.
所屬市場納斯達克
員工數量471
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址The Mediaworks,191 Wood Lane,White City
城市倫敦
省份大倫敦
國家英國
郵編W12 7FP
電話44-20-3829-6230
董事高管
- 姓名
- 職務
- 年薪
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 192.11萬
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Dr. Edgar Braendle
- Senior Vice President and Chief Development Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Robert F. Dolski
- Senior Vice President, Chief Financial Officer
- --
- Alexander Swan
- Senior Vice President, Chief Human Resources Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Martin Pule
- Senior Vice President and Chief Scientific Officer
- --
- Michael W. Bonney
- Chairman of the Board
- --
- Dr. Ravi Madduri Rao
- Director
- --
- Dr. Elisabeth Leiderman, M.D.
- Director
- 1.27萬
- Robert W. Azelby
- Director
- --
- Dr. Martin Murphy, PhD
- Independent Director
- 15.83萬
- Cynthia M. Butitta
- Independent Director
- 16.46萬
- William D. Young
- Independent Director
- 17.58萬
- John E. Berriman
- Independent Director
- 16.31萬
- Dr. Joseph Anderson, PhD.
- Independent Director
- 19.56萬
- Linda C. Bain
- Independent Director
- 16.95萬
- Dr. Robert Iannone, M.D.
- Independent Director
- 13.49萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據